ALG6 alpha-1,3-glucosyltransferase
Ultimo aggiornamento 5 Jul 2022
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
L ALG6 gene provides instructions for making an enzyme that is involved in a process called glycosylation. Glycosylation is a process by which sugar molecules (oligosaccharides) are attached to proteins and fats. Oligosaccharides are made up of many sugar molecules that are attached to one another in a stepwise process forming a complex chain. Glycosylation modifies proteins so they can perform a wider variety of functions. The enzyme produced from the ALG6 gene transfers a simple sugar called glucose to the growing oligosaccharide. Once the correct number of sugar molecules are linked together, the oligosaccharide is attached to a protein or fat.
Scelte video per GenesVideo library
Normal function
L ALG6 gene provides instructions for making an enzyme that is involved in a process called glycosylation. Glycosylation is a process by which sugar molecules (oligosaccharides) are attached to proteins and fats. Oligosaccharides are made up of many sugar molecules that are attached to one another in a stepwise process forming a complex chain. Glycosylation modifies proteins so they can perform a wider variety of functions. The enzyme produced from the ALG6 gene transfers a simple sugar called glucose to the growing oligosaccharide. Once the correct number of sugar molecules are linked together, the oligosaccharide is attached to a protein or fat.
Conditions referring to this gene or chromosome
Altri nomi
asparagine-linked glycosylation 6 homolog (S. cerevisiae, alpha-1,3-glucosyltransferase)
asparagine-linked glycosylation 6 homolog (yeast, alpha-1,3-glucosyltransferase)
asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog
asparagine-linked glycosylation protein 6 homolog
dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase
dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase
dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase precursor
dolichyl-P-Glc:Man(9)GlcNAc(2)-PP-dolichol alpha- 1->3-glucosyltransferase
dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase
dolichyl-P-Glc:Man9GlcNAc2-PP-dolichylglucosyltransferase
Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase
Related patient information and medicines

Patient information leaflet
Test di funzionalità epatica
Changes in liver function tests give a clue as to whether your fegato is under strain, infl... Liver function Liver function The liver is a factory for the production and breakdown of carbohydrates, fats, proteins, hormones and other essential body chemicals, and helps dispose of waste products. Un isolated rise nel un. What does an abnormal.

Patient information leaflet
Insufficienza epatica
This is called chronic liver disease. See the separate leaflet called Cirrhosis for further information. Liver failure can also develop rapidly over just a few days (acute liver failure). How common is liver failure. Acute liver failure is very uncommon: In England , there were 688 liver transplants, 28 in Scotland, 69 in Wales and 24 in Northern.

Patient information leaflet
Prostatite cronica
For chronic prostatitis/CPPS , possible treatments may include the following: Antibiotics - these may be ... It may be that some antibiotics have anti-inflammatory properties as well or that they may clear some germs (bacteria) that are difficult to find when your urine is tested. Alpha-blockers Alpha-blockers - are medicines that are used to.

Patient information leaflet
Screening per la sindrome di Down
The rest of this leaflet concentrates on screening per Sindrome di Down e the diagnosis of Down's syndrome during pregnancy, before the baby is born. What is the difference ... What Down's syndrome screening tests are available? 10-14 weeks - combined test The standard test for Down's syndrome includes a combination of a nuchal translucency scan.

Patient information leaflet
Alta pressione sanguigna
Healthcare professionals sometimes call high blood pressure 'hypertension'. [/health/high-blood-pressure-hypertension](https://patient.info/health/high-blood-pressure-hypertension) Understanding a blood pressure reading Blood pressure readings are given as two numbers, eg 130/80. A blood test to ... A heart tracing, called an.

Patient information leaflet
Posso prendere Carbocisteina e Omega-3 insieme?
Omega-3 fatty acids are nutrients used by the body for various functions, including heart and brain health. Using othe... Our Controllo Interazioni Farmaci helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and what to do.
Ulteriori letture e riferimenti
- ALG6 alpha-1,3-glucosyltransferase; MedlinePlus, National Library of Medicine.
- Grunewald S, Imbach T, Huijben K, Rubio-Gozalbo ME, Verrips A, de Klerk JB, Stroink H, de Rijk-van Andel JF, Van Hove JL, Wendel U, Matthijs G, Hennet T, Jaeken J, Wevers RA. Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis. Ann Neurol. 2000 Jun;47(6):776-81.
- Imbach T, Burda P, Kuhnert P, Wevers RA, Aebi M, Berger EG, Hennet T. A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic. Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6982-7. doi: 10.1073/pnas.96.12.6982.
- Sparks SE, Krasnewich DM. Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. 2005 Aug 15 [updated 2017 Jan 12]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1332/
- Westphal V, Xiao M, Kwok PY, Freeze HH. Identification of a frequent variant in ALG6, the cause of Congenital Disorder of Glycosylation-Ic. Hum Mutat. 2003 Nov;22(5):420-1. doi: 10.1002/humu.9195.
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

